We identified an interaction between AAT and complement component C3 and demonstrated that a by-product of C3 cleavage, C3d, is present at increased levels in the plasma of AATD individuals [19]. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.